Okay, let's tackle this question about antipsychotics with the least extrapyramidal effects. First, I need to remember the different classes of antipsychotics. There are typical and atypical antipsychotics. The typical ones, like haloperidol, are known for their high risk of extrapyramidal side effects (EPS) because they block dopamine D2 receptors in the nigrostriatal pathway. Atypical antipsychotics, such as clozapine, olanzapine, and quetiapine, have a lower incidence of EPS because they have a different receptor profile, maybe more serotonin antagonism and less dopamine blockade.

The question asks for the one with the least EPS. Clozapine is often cited as having the lowest EPS, but it has other issues like agranulocytosis. Quetiapine and olanzapine are also atypical but may still cause some EPS, just less than typical. Risperidone, another atypical, can cause EPS more than clozapine. So the correct answer should be clozapine. The options might include clozapine as option C or D. The incorrect options would be typical antipsychotics or atypicals with higher EPS. Need to make sure the explanation covers why atypicals are better, the mechanism, and why each wrong option isn't correct. Also, the clinical pearl here is that clozapine is the least likely, but it's not always the first choice due to other side effects. High-yield fact: Atypical antipsychotics have lower EPS risk due to 5-HT2A and D4 antagonism. The answer is clozapine.

**Core Concept**
Extrapyramidal side effects (EPS) result from dopamine D2 receptor blockade in the nigrostriatal pathway. Atypical antipsychotics, such as clozapine, have a lower EPS risk due to their higher serotonin (5-HT2A) receptor antagonism and lower dopamine D2 occupancy compared to typical antipsychotics.

**Why the Correct Answer is Right**
Clozapine, an atypical antipsychotic, has the lowest EPS risk because it blocks 5-HT2A receptors more potently than D2 receptors. This "serotonin-dopamine antagonist" profile reduces dopamine antagonism in the nigrostriatal pathway, minimizing EPS. It also has low affinity for D1 and D3 receptors, further reducing extrapyramidal toxicity.

**Why Each Wrong Option is Incorrect**
**Option A:** Haloperidol, a typical antipsychotic, causes high EPS due to strong D2 receptor blockade.
**Option B:** Risperidone, an atypical antipsychotic, has moderate EPS risk because it blocks D2 receptors more than 5-HT2A receptors.
**Option C:** Olanzapine has lower EPS risk than typical agents but higher than clozapine due to its balanced D2/5-HT2A antagonism.

**Clinical Pearl / High-Yield Fact**
Clozapine is the gold standard for treatment-resistant schizophrenia but requires regular blood monitoring due to agranulocytosis risk. Remember: "Clozapine = least EPS, highest agranulocytosis risk."

**Correct Answer: C. Clozapine**

✓ Correct Answer: A. Clozapine